Pharmaceutical composition comprising a zinc-hyaluronate complex for the treatment of multiple sclerosis
The invention relates to pharmaceutical compositions for the treatment of multiple sclerosis which comprises a zinc-hyaluronan complex, preferably a zinc-hyaluronan complex with a molecular weight of 800-1200 kDa, as active ingredient and a pharmaceutically acceptable carrier and/or additive. The pr...
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | English |
Published |
31.05.2007
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The invention relates to pharmaceutical compositions for the treatment of multiple sclerosis which comprises a zinc-hyaluronan complex, preferably a zinc-hyaluronan complex with a molecular weight of 800-1200 kDa, as active ingredient and a pharmaceutically acceptable carrier and/or additive. The process for the preparation of said pharmaceutical compositions as well as the therapeutic use thereof for the treatment of multiple sclerosis are also within the scope of the invention. |
---|---|
Bibliography: | Application Number: US20040579256 |